Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Pilaralisib and Voxtalisib in Cancer
NCT01587040Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2012
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pilaralisib, voxtalisib in malignant neoplasm, sponsored by Sanofi. Started Jul 2012; status: completed.
02
Drugs
pilaralisibvoxtalisib
03
Conditions
malignant neoplasm
Beyond the preview
Go deeper on NCT01587040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01587040.